Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year Ending March 31, 2024
August 06, 2023
Share
Sakai Chemical Industry Co., Ltd. provided consolidated earnings guidance for the six months ending September 30, 2023 and full year ending March 31, 2024. For the six months, the company expected net sales of JPY 43,000 million, Operating profit of JPY 1,200 million, Profit attributable to owners of parent of JPY 400 million and Earnings per share of JPY 24.71.
For the full year, the company expected net sales of JPY 91,000 million, Operating profit of JPY 4,500 million, Profit attributable to owners of parent of JPY 3,600 million and Earnings per share of JPY 222.40.
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year Ending March 31, 2024